India reported approximately 2.8 million tuberculosis (TB) cases in 2023, a slight decrease compared to the previous year. Around 323,000 people died from the disease, and 417,286 cases were either undiagnosed or unreported. Drug-resistant TB continued to pose a serious challenge, with an estimated 110,000 cases.
Over the year, we have contributed to multiple research-focused projects in India, primarily involving the deployment of CAD4TB. In 2017, a CAD4TB was delivered to the Medanta Duke Research Institute to support TB screening. In 2021, we implemented CAD4TB in four districts of Karnataka—Bidar, Yadgir, Gulbarga, and Bijapur—in collaboration with our local partner.
This initiative enabled AI-powered screening closer to communities with high TB prevalence and limited access to diagnostic services.
